Efficacy and Safety of LY01005 in Patients With Prostate Cancer Compared to ZOLADEX®

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a multicenter, randomized, open-label, active comparator-controlled phase Ⅲ trial to compare efficacy and safety of Goserelin Acetate Sustained-Release Microspheres for Injection (LY01005) and ZOLADEX® in patients with prostate cancer.
Epistemonikos ID: 0448ce7fbc7c37026c586b2c7d1f5b05d4170a8f
First added on: May 07, 2024